{"company":{"slug":"precision-neuroscience","name":"Precision Neuroscience","stage":"series-b+","industry":"bio-health","subcategory":null,"sector":"Medical, Medical Device, Neuroscience, Product Research","description":"Unlocking the full potential of the brain.","crypto":false,"first_seen_at":"2026-10-09T13:32:25.476Z","hq_city":"Manhattan","hq_country":"United States","founded_year":null,"website":"https://www.precisionneuro.io","x_handle":"PrecisionNeuro_","followers":1183,"logo":"https://recentfunding.com/logo/e/ur2GMBlT4L7I4Qv3Cy1mNlAxxbE4v1GiEdFcPtb0zcObFmO1YMcyN0DJF0REI59LFgoNmElFyhmGAq-kmT7GGML_M5V38yyHBTrXNTPaHnJVZ_XX9P_pE0QNujto-vpQxjJRsv0L2A","amount_usd":"250000000.00","announced_at":"2026-09-24T00:00:00.000Z","raise_source_url":"https://www.globenewswire.com/news-release/2026/09/24/3368254/0/en/precision-neuroscience-closes-oversubscribed-250m-series-d-led-by-pershing-square-inc-the-ackman-oxman-institute-and-a-leading-life-sciences-investment-fund.html","raise_publisher":"globenewswire.com","raise_provider":"press","sources":[],"investors":["Ackman Oxman Institute","Alumni Ventures","ARK Investment Management","B Capital","Draper Associates","Duquesne Family Office","Forepont Capital Partners","General Equity Holdings","Hitachi Ventures","Invus","JSL Health Capital","Korea Investment Partners","Korean Investment Partners","Mirae Asset Capital","Mubadala Capital Ventures","Pershing Square Inc.","Protocol Labs","re.Mind Capital","Riverhorse Investments","SCI Ventures","Soleus Capital","Steadview Capital"],"flagged":false,"flagged_at":null,"source_links":{},"x_created_at":"2024-01-29","domain_created_at":null,"smart_follows":null,"days_early":null,"new_follows_7d":null,"trending_rank":null,"team_size":null,"team_source_url":null,"acquired_by":null,"categories":["health-bio"]},"rounds":[{"stage":"series-b+","kind":null,"amount_usd":"250000000.00","valuation_usd":null,"announced_at":"2026-09-24T00:00:00.000Z","source_url":"https://www.globenewswire.com/news-release/2026/09/24/3368254/0/en/precision-neuroscience-closes-oversubscribed-250m-series-d-led-by-pershing-square-inc-the-ackman-oxman-institute-and-a-leading-life-sciences-investment-fund.html","source_publisher":"globenewswire.com","source_provider":"press"},{"stage":"series-b+","kind":null,"amount_usd":null,"valuation_usd":null,"announced_at":"2024-11-11T00:00:00.000Z","source_url":"https://www.mobihealthnews.com/news/elon-musks-neuralink-rival-precision-neuroscience-secures-93m","source_publisher":null,"source_provider":null},{"stage":"series-b+","kind":null,"amount_usd":"41000000.00","valuation_usd":null,"announced_at":"2023-01-25T00:00:00.000Z","source_url":"https://www.biospace.com/article/releases/precision-neuroscience-raises-41-million-to-build-and-scale-the-next-generation-of-treatments-for-neurological-illnesses/","source_publisher":null,"source_provider":"scan"},{"stage":"series-a","kind":null,"amount_usd":"12000000.00","valuation_usd":null,"announced_at":"2021-05-25T00:00:00.000Z","source_url":"https://www.prnewswire.com/news-releases/precision-neuroscience-raises-12m-to-develop-next-generation-brain-computer-interface-technology-301298952.html","source_publisher":null,"source_provider":"scan"}],"founders":[{"name":"Benjamin Rapoport","x_handle":null,"linkedin_url":null,"avatar":"https://recentfunding.com/logo/e/UHGkZDAmcsQHM5lgX5lpD4idha4yBbDbJQNop39hDHmA6VyBdoe9RERLNZCHQG46lzpgrqrKId0ELaqc3YyeckeS4IIyHFx8UN4I2X1UNKCpjSu6vHPOdb5J3HJWNmoGNUUr42ro1Q","role":"Founder","source_url":null,"other_companies":[]},{"name":"Demetrios Papageorgiou","x_handle":null,"linkedin_url":"https://www.linkedin.com/in/demetriospapageorgiou","avatar":"https://recentfunding.com/logo/e/oi7CLgi_xVdgLvfiB8kMrg-O8M2au9sJwplEAD5eU9J53SUmhC4H9GKOl2PDHKbRX5UdVyHezVUhzAnUW3suVlcnzA_OFJ27bVUwrXhs0MeOdvEu1-y1ytMAXUcSgX4JXXqQvRbEHDo6vSFovh-_DQpWrXe8psTH0hHnJztpZopjvJCzDrO-A5arQvgY0BLgoMCff7lit57VzO0RGVeskQ_Lx88WuNhAffNwwsXb0tV8ki2OHXq19oy8ujvgbQXLkmBCnvYiR6vAuHE-5iivIc99BAzXEl8Jc4wc6hRV6r2CRSTGGRknjKgyG7Pong","role":"Founder","source_url":null,"other_companies":[]},{"name":"Mark Hettick","x_handle":null,"linkedin_url":null,"avatar":"https://recentfunding.com/logo/e/jEm5mm0Moym-UMUr5itXP43bam0NYabAom6_eKMvAjmusSnZBDOf1NBfQbKblHIxiUeA1Co4wQivr_AaHrAqE8W7_qvkFsnIS-DhkK67IKSxe3MfufsC783vqKGpDXvaoU05U7XdLg","role":"Founder","source_url":null,"other_companies":[]},{"name":"Michael Mager","x_handle":null,"linkedin_url":null,"avatar":"https://recentfunding.com/logo/e/GtkxMnqlLePySWtt5phRIR2sbk5hFBUHa06YntxTO93-AFo8jB5yBX231D0fQFRjTHrJcJVAl6CQWffIWsyB49KC07VXtPM-2USFIAHy7BmfrDtoRz0QVmdGrsK-obgXk24296c5_Q","role":"Founder","source_url":null,"other_companies":[]},{"name":"Jayme Strauss","x_handle":null,"linkedin_url":null,"avatar":"https://recentfunding.com/logo/e/tdKQYFnJzrc0g1BDbTWMEbPxomYFCN6xFJfh8fLX5XtdQwNLoS8vsaQbdKYnA4gCFuXPODG_-uqqgdx8ZOKCQZ9uKfB8TOYXeDRlgv91Bts5T5TtTrt1JtmpXa8uEpMwRfYYh-IOCA","role":"Chief Clinical Officer","source_url":null,"other_companies":[]},{"name":"Joel Greengrass","x_handle":null,"linkedin_url":null,"avatar":"https://recentfunding.com/logo/e/nEdPuEeCKE_m5bA9RnNfcsYzIe8J9gw17rLmx_ZDNVtwbNdK6TmmrhTpkzq3MVe0ntIXHbYVryO0ezvbqVGoOChrEC-mQllQc5eLorUk_p4S1TBq-n_x3ll9G2zxl0lJKLBMqgsX8g","role":"Chief People Officer","source_url":null,"other_companies":[]},{"name":"John Woock","x_handle":null,"linkedin_url":null,"avatar":"https://recentfunding.com/logo/e/qKMNKSquKmDsH4nGInGL8K7zjBdrDSgaNuCLInpg8s_bYbQIsskRI6VvnEgMkn2IkORWnHIleRt9mLvB3tmnkXFCttPlJ9CQZcm7rU6ykuvKyTh7GTv8Px8ueW3muy_NrfFsO9GLtA","role":"Chief Business Officer","source_url":null,"other_companies":[]},{"name":"Michael Kaswan","x_handle":null,"linkedin_url":null,"avatar":"https://recentfunding.com/logo/e/pLgjRv-cEjPedIbFa5iJEnjKQpDDBHax4I7VTpDv2UFcSWcKXrghPvLiCFgi-sGNiqIHGn52zdLVWklT4KfZIHC9NH1Up_anMXqnQ_0dj0cDAHDCajDVmGruJRHK6nXzgJ656FuyCw","role":"Chief Financial Officer","source_url":null,"other_companies":[]},{"name":"Nathan Pletcher","x_handle":null,"linkedin_url":null,"avatar":"https://recentfunding.com/logo/e/wO-9a8CW5GXerjIFHCHeYwYSKWJePWiKJMFc97HXUZSDSpTx9QvW3voUIwp0Tl46Snd6KbpAvIQS_lLEIl1ZKSnJMdGePTigC6y57ehFcq66yuVCxf5XNFQrqdZI1xL5pu-IRw4ByA","role":"Chief Technology Officer","source_url":null,"other_companies":[]}],"meta":{"notice":"No API key: 10000 requests a day per client, then a 429. Get a free key with just an email: POST https://recentfunding.com/api/keys/new with the JSON body {\"email\": \"you@example.com\"} (or use the form at https://recentfunding.com/api-key/). The answer's \"key\" starts with rf_; send it on every request as the header \"Authorization: Bearer rf_...\" (X-API-Key: rf_... or ?api_key=rf_... also work).","get_key":"https://recentfunding.com/api-key/","create_key":{"method":"POST","url":"https://recentfunding.com/api/keys/new","body":{"email":"you@example.com"}},"send_key":"Authorization: Bearer rf_...","daily_limit":10000,"remaining_today":9602}}